AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $17,488 | -49.3% | 60,302 | -21.3% | 0.00% | – |
| Q4 2022 | $34,460 | -13.8% | 76,594 | 0.0% | 0.00% | – |
| Q3 2022 | $40,000 | +2.6% | 76,594 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -77.8% | 76,594 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $176,000 | -51.6% | 76,594 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $364,000 | -12.3% | 76,594 | +46.7% | 0.00% | 0.0% |
| Q3 2021 | $415,000 | +14.3% | 52,204 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $363,000 | -12.1% | 52,204 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $413,000 | +0.5% | 52,204 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $411,000 | +11.1% | 52,204 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $370,000 | -23.4% | 52,204 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $483,000 | +280.3% | 52,204 | +91.9% | 0.00% | +100.0% |
| Q1 2020 | $127,000 | -38.9% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $208,000 | -0.5% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $209,000 | +12.4% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $186,000 | -15.1% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $219,000 | +7.4% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $204,000 | -21.5% | 27,204 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $260,000 | -9.7% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $288,000 | +6.7% | 27,204 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $270,000 | +342.6% | 27,204 | +142.8% | 0.00% | – |
| Q4 2017 | $61,000 | +10.9% | 11,204 | 0.0% | 0.00% | – |
| Q3 2017 | $55,000 | +27.9% | 11,204 | 0.0% | 0.00% | – |
| Q2 2017 | $43,000 | – | 11,204 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |